VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,533,807 | -11.8% | 317,124 | -1.3% | 0.13% | -1.5% |
| Q2 2023 | $9,674,494 | -8.3% | 321,305 | -1.5% | 0.13% | -24.6% |
| Q1 2023 | $10,548,106 | +10.2% | 326,062 | -2.4% | 0.18% | -2.2% |
| Q4 2022 | $9,574,504 | +17.8% | 334,072 | -0.8% | 0.18% | +26.1% |
| Q3 2022 | $8,125,000 | -12.1% | 336,847 | -0.3% | 0.14% | -13.9% |
| Q2 2022 | $9,247,000 | -30.3% | 337,736 | -2.4% | 0.16% | +34.1% |
| Q1 2022 | $13,266,000 | +18.4% | 345,923 | -1.1% | 0.12% | +92.2% |
| Q4 2021 | $11,203,000 | +8.5% | 349,757 | -0.2% | 0.06% | +18.5% |
| Q3 2021 | $10,330,000 | -13.4% | 350,515 | -0.2% | 0.05% | -8.5% |
| Q2 2021 | $11,933,000 | +4.0% | 351,173 | -0.5% | 0.06% | -4.8% |
| Q1 2021 | $11,470,000 | -12.8% | 352,917 | -3.3% | 0.06% | -4.6% |
| Q4 2020 | $13,150,000 | -56.4% | 365,082 | -52.6% | 0.06% | -65.1% |
| Q3 2020 | $30,142,000 | +118.9% | 769,719 | +105.0% | 0.19% | +72.2% |
| Q2 2020 | $13,771,000 | +56.6% | 375,444 | -1.6% | 0.11% | +2.9% |
| Q1 2020 | $8,794,000 | -27.7% | 381,694 | -8.1% | 0.10% | -16.7% |
| Q4 2019 | $12,160,000 | +7.9% | 415,285 | -1.6% | 0.13% | -2.3% |
| Q3 2019 | $11,267,000 | +0.6% | 421,826 | -3.7% | 0.13% | +14.2% |
| Q2 2019 | $11,201,000 | +11.0% | 438,223 | -2.7% | 0.11% | +4.6% |
| Q1 2019 | $10,095,000 | -30.0% | 450,246 | -34.2% | 0.11% | -47.1% |
| Q4 2018 | $14,425,000 | +13.4% | 683,974 | -0.4% | 0.20% | +56.9% |
| Q3 2018 | $12,717,000 | -18.5% | 686,653 | -1.8% | 0.13% | -22.6% |
| Q2 2018 | $15,605,000 | +0.9% | 699,463 | -0.6% | 0.17% | -12.5% |
| Q1 2018 | $15,472,000 | +35.9% | 703,935 | +43.7% | 0.19% | +25.5% |
| Q4 2017 | $11,382,000 | -1.1% | 489,750 | -2.3% | 0.15% | -5.6% |
| Q3 2017 | $11,510,000 | +2.0% | 501,307 | -1.9% | 0.16% | -3.0% |
| Q2 2017 | $11,288,000 | -4.7% | 511,241 | -1.5% | 0.17% | -16.5% |
| Q1 2017 | $11,842,000 | +5.7% | 519,158 | -3.0% | 0.20% | -9.5% |
| Q4 2016 | $11,201,000 | -22.9% | 535,437 | -2.6% | 0.22% | -11.6% |
| Q3 2016 | $14,534,000 | -6.1% | 549,922 | -1.5% | 0.25% | -18.8% |
| Q2 2016 | $15,474,000 | – | 558,410 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |